[1] 姚征,姚庆华,陈玉堂等.动脉化疗栓塞术联合射频消融治疗无法手术的原发性肝癌.肝胆胰外科杂志,2015,27:180-183.
[2] 梁扩寰,李绍白.肝脏病学.第二版.北京:人民卫生出版社,2003,1155.
[3] 朱宇,田银生,葛明刚,等.经肝动脉插管化疗栓塞术联合射频消融术对比射频消融术治疗复发性肝癌的临床研究.临床外科杂志,2014,22:163-166.
[4] 宋杰,王黎洲,李兴,等.肝动脉灌注化疗栓塞联合DSA引导下射频消融术治疗肝癌100例疗效评估.介入放射学杂志,2013,22:810-813.
[5] 程洪涛,郭晨阳,黎海亮,等.TACE联合射频消融治疗原发性肝癌疗效的影响因素分析.介入放射学杂志,2012,21:216-219.
[6] Miyayama S, Yamashiro M, Hashimoto M, et al. Blood supply of the main bile duct from the caudate artery and medial subsegmental artery of the hepatic artery: Evaluation using images obtained during transcatheter arterial chemoembolization for hepatocellular carcinoma. Hepatology research, 2013,43:1175-1181.
[7] 谢小西,吕银祥,章宏欣等.肝动脉化疗栓塞、射频消融联合125Ⅰ粒子植入治疗原发性肝癌的临床应用.介入放射学杂志,2011,20:863-866.
[8] Cha H, Yoon HI, Lee IJ, et al. Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-Confined hepatocellular carcinoma.Journal of Radiation Research, 2013,54:1069-1077.
[9] 陈卫,邓俊,陆忠华,等.肝动脉化疗栓塞术治疗原发性肝癌疗效及影响因素.肝脏,2014,19:28-30.
[10] 廖娟,王春晖,李肖,等.经导管肝动脉化疗栓塞术对原发性肝癌患者细胞免疫及调节T细胞的影响.肝脏,2011,16:198-201.
[11] Han X, Cheng W, Jing H, et al. Neuroepithelial transforming protein 1 short interfering RNA-mediated gene silencing with microbubble and ultrasound exposure inhibits the proliferation of hepatic carcinoma cells in vitro.Journal of Ultrasound in Medicine, 2012,31: 853-861.
[12] 孙贤俊,何胜利,沈婕,等.射频消融联合经动脉化疗栓塞治疗肝癌的疗效分析.中国临床医学,2011,18:803-808. |
